FDA clears digital tool to help diagnose autism in children as young as 16 months

Photo caption: The EarliPoint Evaluation uses eye-tracking technology to monitor a child’s focus and responsiveness to social interactions, then compares those results to expected benchmarks. Photo credit: Getty Images. Article by Andrea Park. Fierce Biotech – June 13, 2022.

Diagnoses of autism spectrum disorder have skyrocketed in the U.S. since the turn of the millennium, when one in every 150 children were diagnosed with the condition. Two decades later, according to the CDC, that now includes one in every 44 children, measured among the nation’s 8-year-olds. Despite […]

Click here to view original web page at www.fiercebiotech.com